(PRWEB) August 29, 2013
The Corporate Whistleblower Center says, "Pharmaceutical representatives, or physicians should pay attention when the United States Department of Justice jumps into a whistleblower case involving medical doctors, a big drug company, and kickbacks, because it is a signal someone probably is going to get a huge whistleblower reward. Because of this development we are going to expand all of our big pharma, and medical doctor kickback inititiatives. While the Justice Department has not yet declared a settlement, the fact that they jumped into this alleged misconduct is a very big deal, and we want to help potential whistleblowers cash in on their information, if they have proof of drug companies paying off doctors, to prescribe more drugs."
According to a April 16th 2013 national press release from the Justice Department, "As alleged, Novartis corrupted the prescription drug dispensing process with multi-million dollar ‘incentive programs’ that targeted doctors who, in exchange for illegal kickbacks, steered patients toward its drugs." The Corporate Whistleblower Center is urging pharmaceutical representatives, or for that matter medical doctors to call them, if they possess information related to big drug companies paying off doctors with kickbacks. For more information potential whistleblowers are encouraged to contact the Corporate Whistleblower Center anytime at 866-714-6466.
Simple rules for a whistleblower from the Corporate Whistle Blower Center:
Any type of insider, or employee, who possesses significant proof of their employer, or a private contractor is fleecing the federal government out of millions of dollars is encouraged to contact to Corporate Whistleblower Center anytime at 866-714-6466, or they can contact the group via their web site at http://CorporateWhistleblowerCenter.Com
For attribution purposes please read the United States Department of Justice's press release titled: United States Files Complaint Against Novartis Pharmaceuticals Corp. for Allegedly Paying Kickbacks to Doctors in Exchange for Prescribing Its Drugs, dated April 26th 2013: http://www.justice.gov/opa/pr/2013/April/13-civ-481.html
Case Number Information: The lawsuit is United States ex rel. Bilotta v. Novartis Pharmaceuticals Corporation et al., No. 11-cv-0071 (S.D.N.Y.).